Use of long-acting opioid-addiction treatment increases, but lags other forms

A new Rutgers University study published in the journal Health Affairs shows use of a long-acting injectable form of opioid treatment has increased nationwide and in New Jersey, but lags other versions of the medication.

By: Lilo H. Stainton

Outlets: New Jersey Monitor

Published: July 13, 2026

Words: 662

Last Updated: 1 week, 2 days ago

Body Text Preview

Use of long-acting injectable forms of buprenorphine — the gold-standard for opioid treatment — has grown significantly in New Jersey over the past years, mirroring a national trend.

However, fewer than 5% of Garden State patients prescribed buprenorphine chose the injectable version of the medication, according to a Rutgers University study published earlier this month in the journal Health Affairs.

Researchers from Rutgers and Columbia University studied nearly 2.3 million …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us